These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1478034)

  • 1. Risk factors for peripheral vascular disease in hypertensive subjects with type 2 diabetes mellitus.
    Alcolado JC; Pacy PJ; Beevers M; Dodson PM
    Diabet Med; 1992 Dec; 9(10):904-7. PubMed ID: 1478034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum lipoprotein(a) is increased in hypertensive NIDDM patients.
    Hancu N; Netea MG; Iancu S
    Diabetes Care; 1995 Jun; 18(6):879-80. PubMed ID: 7555518
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of the ACE inhibitor lisinopril on blood pressure, metabolism, and renal function parameter in hypertensive type II diabetic patients: a postmarketing surveillance study.
    Hasslacher C
    J Diabetes Complications; 1996; 10(3):136-8. PubMed ID: 8807458
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk factor analyses for macrovascular complication in nonobese NIDDM patients. Multiclinical Study for Diabetic Macroangiopathy (MSDM).
    Ito H; Harano Y; Suzuki M; Hattori Y; Takeuchi M; Inada H; Inoue J; Kawamori R; Murase T; Ouchi Y; Umeda F; Nawata H; Orimo H
    Diabetes; 1996 Jul; 45 Suppl 3():S19-23. PubMed ID: 8674883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of cardiometabolic parameters in non-smokers, current smokers, and quitters in diabetes: a systematic review and meta-analysis.
    Kar D; Gillies C; Zaccardi F; Webb D; Seidu S; Tesfaye S; Davies M; Khunti K
    Cardiovasc Diabetol; 2016 Nov; 15(1):158. PubMed ID: 27881170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein(a) is an independent risk factor for peripheral arterial disease in Chinese type 2 diabetic patients in Taiwan.
    Tseng CH
    Diabetes Care; 2004 Feb; 27(2):517-21. PubMed ID: 14747238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversed circadian blood pressure rhythm is associated with occurrences of both fatal and nonfatal vascular events in NIDDM subjects.
    Nakano S; Fukuda M; Hotta F; Ito T; Ishii T; Kitazawa M; Nishizawa M; Kigoshi T; Uchida K
    Diabetes; 1998 Sep; 47(9):1501-6. PubMed ID: 9726241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for the development of micro-vascular complications of type 2 diabetes in a single-centre cohort of patients.
    Teliti M; Cogni G; Sacchi L; Dagliati A; Marini S; Tibollo V; De Cata P; Bellazzi R; Chiovato L
    Diab Vasc Dis Res; 2018 Sep; 15(5):424-432. PubMed ID: 29911415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of micro- and macroalbuminuria in a Canarian population of type 2 diabetic patients. Relationship with blood pressure, lipid profile, obesity and metabolic control.
    De Pablos PL; Martinez J; Martinez MP; Doreste JA
    Diabetes Metab; 1998 Sep; 24(4):337-43. PubMed ID: 9805644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein(a) and cardiovascular disease in type 2 (non-insulin-dependent) diabetic patients with and without diabetic nephropathy.
    Nielsen FS; Voldsgaard AI; Gall MA; Rossing P; Hommel E; Andersen P; Dyerberg J; Parving HH
    Diabetologia; 1993 May; 36(5):438-44. PubMed ID: 8314449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase in thiobarbituric acid-reactive substances and vascular complications in type 2 diabetes mellitus.
    Gallou G; Ruelland A; Campion L; Maugendre D; Le Moullec N; Legras B; Allannic H; Cloarec L
    Diabete Metab; 1994; 20(3):258-64. PubMed ID: 8001713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid levels and peripheral vascular disease in diabetic and non-diabetic subjects.
    O'Neal DN; Lewicki J; Ansari MZ; Matthews PG; Best JD
    Atherosclerosis; 1998 Jan; 136(1):1-8. PubMed ID: 9544725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of macrovascular diseases in NIDDM patients in northern Taiwan. A 4-yr follow-up study.
    Fu CC; Chang CJ; Tseng CH; Chen MS; Kao CS; Wu TJ; Wu HP; Chuang LM; Chen CJ; Tai TY
    Diabetes Care; 1993 Jan; 16(1):137-43. PubMed ID: 8422768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between ethnicity and glycemic control, lipid profiles, and blood pressure during the first 9 years of type 2 diabetes: U.K. Prospective Diabetes Study (UKPDS 55).
    Davis TM; Cull CA; Holman RR;
    Diabetes Care; 2001 Jul; 24(7):1167-74. PubMed ID: 11423497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low circulating levels of insulin-like growth factor binding protein-1 (IGFBP-1) are closely associated with the presence of macrovascular disease and hypertension in type 2 diabetes.
    Heald AH; Siddals KW; Fraser W; Taylor W; Kaushal K; Morris J; Young RJ; White A; Gibson JM
    Diabetes; 2002 Aug; 51(8):2629-36. PubMed ID: 12145180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum concentrations of laminin-P1 in diabetes mellitus: usefulness as an index of diabetic microangiopathy.
    Simó R; Masmiquel L; García-Pascual L; Burgos R; Mateo C; Segura RM; Mesa J
    Diabetes Res Clin Pract; 1996 Apr; 32(1-2):45-53. PubMed ID: 8803481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance and coronary risk factors in Japanese type 2 diabetic patients with definite coronary artery disease.
    Matsumoto K; Kizaki Y; Fukae S; Tomihira M; Sera Y; Ueki Y; Tominaga T; Miyake S
    Diabetes Res Clin Pract; 2001 Mar; 51(3):181-6. PubMed ID: 11269890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of temocapril hydrochloride on serum lipid levels in patients with hypertensive type 2 diabetes mellitus.
    Miyashita Y; Ito Y; Hasiguchi S; Totsuka M; Aoki A; Kurokawa M; Tomioka H; Shirai K
    J Atheroscler Thromb; 2001; 8(1):25-9. PubMed ID: 11686312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethnicity and glycaemic control are major determinants of diabetic dyslipidaemia in Malaysia.
    Ismail IS; Nazaimoon W; Mohamad W; Letchuman R; Singaraveloo M; Hew FL; Shuguna C; Khalid BA
    Diabet Med; 2001 Jun; 18(6):501-8. PubMed ID: 11472471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinogen and von Willebrand factor in IDDM: relationships to lipid vascular risk factors, blood pressure, glycaemic control and urinary albumin excretion rate: the EURODIAB IDDM Complications Study.
    Greaves M; Malia RG; Goodfellow K; Mattock M; Stevens LK; Stephenson JM; Fuller JH
    Diabetologia; 1997 Jun; 40(6):698-705. PubMed ID: 9222650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.